A randomized controlled study of convalescent plasma for individuals hospitalized with COVID-19 pneumonia

Penn Spinout Verismo Therapeutics Raises $16M to Advance Cell Therapies

Cellular therapy in preclinical development to target pancreatic cancer, mesothelioma and ovarian cancer.

NIH MERIT Award for Dr. Una O'Doherty

R37 MERIT Award through the National Institute of Allergy and Infectious Diseases (NIAID) for the project "Determinants of Reservoir Contraction and Expansion in vivo, ex vivo, and in vitro" in HIV antiviral therapy (ART).

Convalescent Plasma Therapy for COVID-19 Patients

Experimental approach of giving a transfusion of plasma collected from a donor who has recovered from COVID-19 to a patient with an active infection is the focus of a new two-part research initiative.

CRISPR-engineered T cells in Patients with Refractory Cancer

Genetically-edited immune cells can persist, thrive, and function months after a cancer patient receives them, according to new data published in Science by researchers from the Abramson Cancer Center.

CRISPR-engineered T cells in patients with refractory cancer

Genetically-edited immune cells can persist, thrive, and function months after a cancer patient receives them, according to new data published by researchers from the Abramson Cancer Center.